Literature DB >> 10898924

Five missense variants in the amino-terminal domain of the glucocorticoid receptor: no association with puerperal psychosis or schizophrenia.

J Feng1, J Zheng, W P Bennett, L L Heston, I R Jones, N Craddock, S S Sommer.   

Abstract

Steroid hormone administration causes behavior changes in many and psychosis in a few. The clinical features suggest that genetic variants of the glucocorticoid receptor or cofactors could produce susceptible subpopulations who react adversely to hormonal cascades. To investigate this possibility, coding and splice site sequences of the glucocorticoid receptor were scanned for single nucleotide polymorphisms in genomic DNA samples from 100 schizophrenics (86 Caucasians and 14 African-Americans) and 40 Caucasians with puerperal psychosis. Five amino acid substitutions were found in the amino-terminal domain at frequencies of 0.6 to 3.8% in Caucasians: R23K, F29L, L112F, D233N, and N363S. In addition, four silent nucleotide changes were found: E22E, K293K, D677D, and N766N; a transversion in intron 4 occurred beyond the splice junction. None of these variants can be linked to these disorders at present. However, the N363S variant contributes a new potential phosphorylation site and has been associated with increased body mass and reduced bone mineral density [Huizenga et al., 1998], so it is possible that the other missense variants confer traits that currently are unrecognized. Comparisons to natural glucocorticoid receptor mutants in the familial glucocorticoid resistance syndrome and steroid resistant leukemias suggest that amino acid substitutions at highly conserved residues may cause severe functional defects and serious illness, while changes at less conserved sites produce lesser alterations and milder disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898924     DOI: 10.1002/1096-8628(20000612)96:3<412::aid-ajmg33>3.0.co;2-c

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

Review 1.  Postpartum psychoses: prognosis, risk factors, and treatment.

Authors:  Bruno Pfuhlmann; Gerald Stoeber; Helmut Beckmann
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.

Authors:  Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

3.  Genomic survey of prepulse inhibition in mouse chromosome substitution strains.

Authors:  M P Leussis; M L Frayne; M Saito; E M Berry; K A Aldinger; G N Rockwell; R P Hammer; A E Baskin-Hill; J B Singer; J H Nadeau; P Sklar; T L Petryshen
Journal:  Genes Brain Behav       Date:  2009-07-21       Impact factor: 3.449

4.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

5.  Characterization of a novel gain of function glucocorticoid receptor knock-in mouse.

Authors:  Junhui Zhang; Renshang Ge; Catherine Matte-Martone; Julie Goodwin; Warren D Shlomchik; Mark J Mamula; Ali Kooshkabadi; Matthew P Hardy; David Geller
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

6.  Genome-wide linkage and follow-up association study of postpartum mood symptoms.

Authors:  Pamela Belmonte Mahon; Jennifer L Payne; Dean F MacKinnon; Francis M Mondimore; Fernando S Goes; Barbara Schweizer; Dubravka Jancic; William H Coryell; Peter A Holmans; Jianxin Shi; James A Knowles; William A Scheftner; Myrna M Weissman; Douglas F Levinson; J Raymond DePaulo; Peter P Zandi; James B Potash
Journal:  Am J Psychiatry       Date:  2009-09-15       Impact factor: 18.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.